{"id":15300,"date":"2025-11-26T10:11:14","date_gmt":"2025-11-26T15:11:14","guid":{"rendered":"https:\/\/americacellbank.com\/how-regenerative-medicine-supports-liver-and-cardiovascular-health\/"},"modified":"2026-07-03T08:47:48","modified_gmt":"2026-07-03T13:47:48","slug":"how-regenerative-medicine-supports-liver-and-cardiovascular-health","status":"publish","type":"post","link":"https:\/\/americacellbank.com\/en\/how-regenerative-medicine-supports-liver-and-cardiovascular-health\/","title":{"rendered":"How regenerative medicine supports liver and cardiovascular health"},"content":{"rendered":"\n

The liver and the cardiovascular system are two essential pillars of human health. The former acts as the primary organ for detoxification and metabolism, while the latter ensures the efficient distribution of oxygen and nutrients. However, the modern lifestyle, characterized by a sedentary routine, poor diet, and stress, has alarmingly increased the incidence of liver and cardiovascular diseases. <\/p>\n\n

Given this scenario, regenerative medicine emerges as an innovative approach that utilizes the body’s natural capabilities to repair, replace, and regenerate damaged tissues. Through therapies involving mesenchymal stem cells (MSCs), exosomes, and growth factors, medical science is achieving promising results in pathologies previously considered irreversible. <\/p>\n\n

The importance of the liver and cardiovascular system<\/strong><\/h2>\n\n

The liver performs over 500 vital functions: it metabolizes nutrients, synthesizes proteins, regulates cholesterol, and eliminates toxins. Its natural regenerative capacity is unique but can be compromised by chronic diseases such as non-alcoholic fatty liver disease (NAFLD), chronic hepatitis, or cirrhosis. <\/p>\n\n

Meanwhile, the cardiovascular system, composed of the heart and blood vessels, maintains bodily homeostasis. Diseases such as hypertension, atherosclerosis, and heart failure affect millions of people worldwide and are the leading cause of global mortality. <\/p>\n\n

Both systems are closely related. In fact, cardiohepatic syndrome or fatty liver-associated heart disease are manifestations of a common inflammatory metabolic axis. <\/p>\n\n

Regenerative medicine: a new therapeutic frontier<\/strong><\/h2>\n\n

Regenerative medicine focuses on restoring organ and tissue function through advanced biological therapies. Mesenchymal stem cells (MSCs), derived from umbilical cord, bone marrow, or adipose tissue, possess three essential properties: <\/p>\n\n

    \n
  1. Cellular regeneration:<\/strong> they stimulate the proliferation and differentiation of the affected organ’s own cells.
    <\/li>\n\n\n\n
  2. Immunological modulation:<\/strong> they reduce chronic inflammation that damages tissues.
    <\/li>\n\n\n\n
  3. Paracrine effect:<\/strong> they release exosomes and growth factors that promote tissue repair and angiogenesis.
    <\/li>\n<\/ol>\n\n

    These characteristics make MSCs and their derivatives (such as exosomes) a safe and effective therapeutic tool for liver and cardiovascular diseases.<\/p>\n\n

    Applications in liver health<\/strong><\/h2>\n\n

    1. Non-alcoholic fatty liver disease (NAFLD)<\/strong><\/h3>\n\n

    Fatty liver has become a silent epidemic associated with obesity, insulin resistance, and metabolic syndrome. Studies with umbilical MSCs have shown significant improvements in ALT, AST, and triglyceride levels, as well as reduced inflammation and liver fibrosis.
    MSCs-derived exosomes also regulate hepatic macrophage activity and decrease oxidative stress, promoting natural liver regeneration. <\/p>\n\n

    2. Liver cirrhosis<\/strong><\/h3>\n\n

    Cirrhosis involves advanced fibrosis and functional loss of liver tissue. Clinical research shows that MSC infusion can improve liver function, increase serum albumin, and decrease bilirubin, leading to a better quality of life and delayed disease progression. <\/p>\n\n

    3. Hepatitis and toxic damage<\/strong><\/h3>\n\n

    In experimental models, MSCs show a potent antifibrotic and hepatoprotective effect, even against drug-induced damage or viral hepatitis. Their immunoregulatory action reduces inflammation without completely suppressing the immune response, an advantage over conventional immunosuppressants. <\/p>\n\n

    Applications in cardiovascular health<\/strong><\/h2>\n\n

    1. Acute myocardial infarction<\/strong><\/h3>\n\n

    The loss of cardiac tissue after an infarction is irreversible with traditional treatments. In contrast, MSCs can promote myocardial regeneration<\/strong> by releasing angiogenic factors (VEGF, HGF, IGF-1) and exosomes that stimulate the formation of new blood vessels and improve cardiac contractility. <\/p>\n\n

    Clinical trials in Circulation Research<\/em> report a reduction in infarct size and improved ventricular ejection fraction after treatment with mesenchymal stem cells.<\/p>\n\n

    2. Peripheral ischemia and vascular disease<\/strong><\/h3>\n\n

    In patients with critical limb ischemia, regenerative medicine has been shown to stimulate neovascularization and reduce amputation. Exosomes, being smaller and easier to administer, show enormous potential as a non-invasive alternative. <\/p>\n\n

    3. Systemic inflammation and atherosclerosis<\/strong><\/h3>\n\n

    Atherosclerosis is a chronic inflammatory process of the arteries. MSC exosomes modulate endothelial function, reduce lipid deposition, and regulate pro-inflammatory cytokines, contributing to better vascular health and reduced cardiovascular risk. <\/p>\n\n

    <\/p>\n\n

    \"\"<\/figure>\n\n

    Liver-heart connection: the metabolic and regenerative axis<\/strong><\/h2>\n\n

    The liver and heart are linked by a complex metabolic axis. An inflamed liver produces cytokines (such as TNF-\u03b1 and IL-6) that promote insulin resistance, endothelial dysfunction, and atherogenesis. In turn, poor circulation reduces hepatic oxygenation, aggravating the injury. <\/p>\n\n

    Regenerative medicine can break this vicious cycle by:<\/p>\n\n